1. Introduction {#sec1}
===============

According to a 2018 report of the World Health Organization (WHO) \[[@B1]\], although the incidence and mortality of tuberculosis (TB) in China have been declining slowly in recent years, China still had the second highest burden of TB in the world, with about 889,000 new cases of TB and 388,000 deaths in 2017, second only to India. Thus, TB is still a major problem, endangering the health of Chinese people.

Spinal tuberculosis (STB), which accounts for half of bone and joint TB and is the most common form of extrapulmonary TB, often leads to irreversible neurological injury, including paralysis, resulting in serious social and economic problems \[[@B2]\]. STB is a chronic disease that is slowly progressive, and diagnosing it is relatively difficult \[[@B3]\].

Progression of STB may cause spinal deformity and neurological injury, including paralysis, which seriously affect the quality of lives of affected patients and are difficult to cure by chemotherapy drugs. Anti-TB drug chemotherapy is the major means of treating STB and is the fundamental means of curing STB, with surgery being an adjuvant means of treatment \[[@B4], [@B5]\].

Clinical data concerning TB differ according to differences in geographical locations, life style, level of economic development, level of available medical services, and other factors. In Hunan province, located in south-central China, there is a high incidence (83.0/10 million) and high number of reported cases (55,919 cases) of pulmonary tuberculosis (PTB), resulting in this province ranking in the top eight and three provinces of China, respectively (data obtained from the notifiable PTB report of the Chinese Infectious Disease Report System \[IDRS\]). A number of epidemiological studies of PTB in Hunan have been published, but none concerning STB. This is also true for throughout China.

In this study, clinical data of inpatients with STB in Changsha, Hunan, from 2007 to 2016, including general information, symptoms of TB, diagnosis, treatment, and prognosis, were collected and analyzed to help in the prevention, diagnosis, treatment, and prognosis of STB in Hunan province.

2. Materials and Methods {#sec2}
========================

2.1. Patients Survey {#sec2.1}
--------------------

In this retrospective study, the medical records of inpatients admitted for STB to several large comprehensive hospitals in Changsha, Hunan, China, from January 2007 to December 2016 were collected and reviewed.

Diagnosis of STB was established by clinical, laboratory, and imaging investigations supplemented by pathological examination of biopsy specimens. The diagnosis was based on the following criteria: (1) clinical symptoms and signs such as backache, spinal deformity, neurological deficit (numbness, weakness, dysesthesia, dyskinesia, and paralysis), systemic toxicity symptoms (STS) of TB, including low-grade fever, night sweats and emaciation; (2) computed tomography (CT) and magnetic resonance imaging (MRI) manifestations, such as destruction of vertebral bone, intervertebral space involvement, kyphosis, paravertebral abscess formation, and dural sac compression; (3) laboratory findings including high erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) concentration, positive T-SPOT, TB antibody (IgG and IgM), and tuberculin test; (4) diagnostic anti-TB treatment was effective when it was difficult to otherwise make a definite diagnosis; (5) pathological evidence of TB, such as typical TB with caseous necrosis microscopically, was regarded as the golden standard of diagnosis.

All patients who were diagnosed with STB were routinely treated with the HREZ anti-TB chemotherapy regimen for 12--18 months, namely, rifampicin (450 mg/day), isoniazid (300 mg/day), ethambutol (750 mg/day), and pyrazinamide (750 mg/day). Kidney function and liver function were monitored during anti-TB chemotherapy.

Indications for surgery for STB were as follows: (1) progressive or severe neurological damage, (2) bone destruction of various degrees with severe or developing spinal deformity, (3) persistent back pain due to spinal instability, and (4) poor response to medical treatment.

2.2. Clinical Data {#sec2.2}
------------------

On hospital admission, personal characteristics, clinical manifestations, imaging findings, comorbidities, treatment, and prognostic indicators were collected and analyzed. Patients with missing personal, clinical, or examination data were excluded from the study. Detailed clinical data, including sex, age, place of residence (rural versus urban), occupation, local pain, radicular pain, STS, abscess, neurological injury, involved vertebrae, locations of lesions, concomitant PTB or diabetes, and treatment, were summarized. The American Spinal Injury Association (ASIA) impairment scale was applied to score neurological function. Correlations between variables and years of study were analyzed.

Patients with STB were divided into two groups according to the year of admission, Group A from January 2007 to December 2011 and Group B from January 2012 to December 2016, and variables were assessed comparing the two groups. Trends in changes of each variable were summarized. Because STB is considered to originate from PTB and diabetes is a common comorbidity of STB, correlations between PTB, diabetes, and STB were analyzed.

Follow-up information was obtained by telephone, through e-mail, and during return visits to the outpatient department. "Cure" was defined as follows: no recurrence of TB lesions within 2 years after treatment, maintenance of ESR within the normal range, identification of bone union in lesions by radiographic examination, and disappearance of clinical symptoms for 3 months.\[[@B6]\]

2.3. Statistical Analysis {#sec2.3}
-------------------------

Statistical analysis of the experimental data was performed with the *χ*^2^ test using SPSS 24.0 software (SPSS, Chicago, IL, USA). P \< 0.05 was considered to denote significant differences.

3. Results {#sec3}
==========

3.1. Demographic, Epidemiological, and Personal Characteristics {#sec3.1}
---------------------------------------------------------------

During the years of this study, there were 1378 eligible inpatients with STB. [Table 1](#tab1){ref-type="table"} shows the demographic, epidemiological, and personal characteristics of the study patients. During this 10-year period, the incidence of STB was relatively stable (116--170 new cases per year). The study cohort comprised 805 (58.4%) male and 573 (41.6%) female patients. In the 10 years of the study, there were always more male than female patients. Additionally, there was no significant difference in the ratio of male to female during these 10 years (P \> 0.05).

The age range was 1--88 years, with the mean age being 43.7 years. Specifically, 561 patients (40.7%) were aged from 18 to 45 years, followed by the 46--60 years-old (27.2%). As to place of residence, urban patients accounted for 29.2% (375/1378) and rural patients 72.8% (1003/1378) of the cohort. The mean interval between symptom onset and diagnosis in the hospital was 16.0 months (range 15 days--240 months), this interval being a mean of 22.0 months in rural patients and 9.6 months in urban patients; this difference is significant (P\<0.05). In addition, the distribution of patients with STB in various cities of Hunan province is shown in [Figure 1](#fig1){ref-type="fig"} (Changsha, 15.53%; Shaoyang, 11.68%; Yueyang, 9.43%; Yiyang, 9.29%; Loudi, 8.78%; Yongzhou, 8.06%; Hengyang, 6.68%; Zhuzhou, 6.46%; Changde, 5.95%; Xiangtan, 3.70%; Zhangjiajie, 3.05%; Chenzhou, 2.18%; Huaihua, 2.98%; Xiangxi, 1.89%). The remaining 4.35% were from Jiangxi and Guizhou province, both adjoining Hunan province.

As to distribution of occupations, there were 659 farmers (47.8%), 259 manual workers (18.8%), 128 students (9.3%), and 332 with other occupations (24.1%). The correlation between occupations and years \`was analyzed. Distribution of occupation did not differ significantly over time (P \> 0.05).

3.2. Clinical Presentation {#sec3.2}
--------------------------

As to the clinical presentation of patients with STB ([Table 2](#tab2){ref-type="table"}), 92.5% presented with back pain and the remaining 7.5% with spinal deformity or numbness in the limbs without back pain. The incidences of radicular pain and STS in patients with STB were 40.1% and 32.1%, respectively. Analysis of correlations between back pain and radicular pain and year of study showed no significant change in the incidence of these symptoms over the 10 years (P \> 0.05). As to distribution of severity of neurological injury, 21 (1.5%) patients had ASIA Grade A deficits, 38 (2.8%) Grade B, 111 (8.1%) Grade C, 517 (37.5%) Grade D, and 691 (50.1%) Grade E.

3.3. Imaging Findings {#sec3.3}
---------------------

As shown in [Table 3](#tab3){ref-type="table"}, the lumbar segment was the most frequently affected site (38.2%), followed by the thoracic (35.7%), lumbosacral (8.0%), thoracolumbar (7.9%), cervical (6.4%), and cervicothoracic spines (3.0%), the sacrococcygeal area being the least frequently involved (0.8%). There was STB in two or more vertebrae in 91.1% of patients, in 67.9% of whom two adjacent vertebrae were involved. Abscesses were detected by CT or MRI in 903 of 1378 patients (65.5%), including paraspinal, prevertebral and psoas abscesses.

3.4. Treatment and Prognosis {#sec3.4}
----------------------------

As to distribution of treatment ([Figure 2](#fig2){ref-type="fig"}), 1000 patients (72.6%) were treated surgically and 378 (27.4%) with anti-TB drugs only. The proportion of patients undergoing surgery did not differ significantly over the 10 years of the study (P \> 0.05). The surgical approach (single anterior, single posterior, or combined anterior--posterior approach) was selected on the basis of each patient\'s condition. Minimally invasive CT-guided percutaneous catheter drainage and focal catheter infusion was used in patients with huge iliopsoas abscesses; these procedures are included in the surgical group.

As to distribution of prognosis ([Figure 3](#fig3){ref-type="fig"}), 1215 patients (88.2%) gradually achieved cure within 18 months after hospital admission and initiation of treatment. The 49 patients (3.5%) who relapsed all had postoperative recurrences and required retreatment in hospital. Relapses were presented as postoperative recurrence of TB lesions, abscess formation, sinus formation, progressive kyphosis, or internal fixation fractures, all of which were treated by revision surgery. Follow-up data on the other 114 patients (8.3%) were incomplete. They included patients who were transferred to specialized TB hospitals, those with lost contact, those not cured, and those who died. Poor compliance was the main reason for patients not achieving cure. One death was due to systemic infection.

3.5. Comorbidities {#sec3.5}
------------------

Concomitant PTB, including a previous history of PTB, was present in 366 (26.6%) patients ([Figure 4](#fig4){ref-type="fig"}), whereas 63 patients (4.6%) had concomitant diabetes ([Figure 5](#fig5){ref-type="fig"}). The proportion of patients with STB accompanied by PTB or diabetes did not differ significantly over the 10 study years (P \> 0.05). Among other complications, two patients with thoracolumbar STB had accompanying renal TB and one with cervical STB had accompanying lymph node TB. None of the patients in this study were HIV-positive.

Correlations between various variables and STB and PTB are shown in [Table 4](#tab4){ref-type="table"}. Of the patients with PTB, 63.4% were males, 70.8% had accompanying abscesses, 37.7% had STS, 56.6% had accompanying neurological damage, and 61.2% received non-surgical treatment only. Sex, abscess, STS, neurological injury, and surgery were positively correlated with PTB (P \< 0.05). The cure rate did not differ significantly between patients with and without PTB (P \> 0.05).

Of the patients with concomitant diabetes, 87.3% were middle-aged or older, 44.4 % had STS, 46.0% required non-surgical treatment only, and the cure rate was 76.2% ([Table 5](#tab5){ref-type="table"}). Age, STS, surgery and prognosis were correlated with the presence of diabetes (P \< 0.05).

3.6. Comparison of Data according to Time Period {#sec3.6}
------------------------------------------------

Comparisons of data in the first and second group of 5 years are shown in [Table 6](#tab6){ref-type="table"}. Group A (January 2007--December 2011) comprised 654 patients and Group B (January 2012--December 2016) 724. There was a greater proportion of patients aged over 60 years, urban patients, and medical staff with STB in Group B than in Group A (P \< 0.05), the proportion of older patients, urban patients, and medical staff with STB having increased by 6.1%, 5.2%, and 1.3%, respectively.

4. Discussion {#sec4}
=============

According to a 2017 WHO report \[[@B1]\], 603,000 male and 292,000 female patients were newly diagnosed with TB in China, this male to female ratio being 2.1:1. In the present study, the male to female ratio of the 1378 patients with STB was 1.4:1, and there was no significant change in that ratio over the 10 years of the study. Young and middle-aged adults (18--60 years old) accounted for 1378 (69.9%) of the patients with STB. This age group provides the main labor force, which is important in that long-term physical labor increases the load on and activity of the spine, resulting in chronic spinal damage, thus increasing susceptibility to MTB. Children had the lowest incidence (7.3%), which may be attributable to the protective effect of BCG inoculation, which is sustained into adolescence \[[@B7]\].

In 2010, the fifth national TB survey showed an increase in the number of older patients with bone and joint TB \[[@B8]\], and in the present study we found that the number of patients aged \>60 years increased significantly over time. This increase in older patients may be associated with the aging of the general population \[[@B9]\], lengthening lifespans, poor immunological function, and the increased number of comorbidities in this age group \[[@B10]\]. In addition, STB in older persons is characterized by complexity, disease, slow recovery, resistance to treatment, and atypical symptoms \[[@B11]\]. This trend has hampered developments in public health and social conditions and increased difficulties in prevention and treatment of STB.

Worldwide, 80% of patients with STB are in developing countries and poverty-stricken areas. In China, 80% of patients with STB are in rural areas \[[@B8]\]. In this study, 72.8% patients were from rural areas, which are associated with poor economic level and poor medical and health conditions. The proportion of urban patients with STB increased from 24.5% to 29.7% between the two five-year periods of the present study; this may be related to the increasing proportion of Chinese persons in urban areas. Developments in transportation and increases in population mobility may have contributed to this change. We identified more patients with STB in Changsha, Shaoyang, Yueyang, and Yiyang than in other cities of Hunan province. Possible reasons for this discrepancy may include comprehensive factors affecting the availability of treatment, the population of each city, and variations in economic situation between regions. Thus, screening for STB is recommended for improving prevention, early diagnosis, and treatment of STB in the cities with a high incidence of this condition.

In this study, 66.6% of the patients were farmers and manual workers, who had been engaging in stooped labor, which may increase the prevalence of STB. It is worth noting that the incidence of medical staff increased significantly (P \< 0.05) over the 10 years of the study. Medical staff are exposed to patients with diagnosed or suspected TB, which confers a high risk of TB infection \[[@B12]\].

Back pain is the most frequent symptom of STB \[[@B13]\]. Such pain is typically localized to the site of involvement, which is most commonly the thoracic and lumbar spine. In one study, chronic back pain was the only symptom in 61% of patients with STB \[[@B3]\]. In the present study, 92.5% of inpatients had pain at the site of lesion and this was the main reason for patients seeking medical evaluation and treatment. The mechanisms by which STB causes pain are as follows. First, pain may be caused by spinal instability due to destruction of the vertebral body. Second, neuropathic pain may result from inflammatory stimuli associated with TB lesions, such as abscesses and necrotic bone. Radicular pain was present in 40.1% of our patients as a result of inflammatory stimuli of nerve root. STS of TB, indicating presence of active disease, are present in approximately 20%\~30% of patients with osteoarticular TB \[[@B13]\]. In this study, 32.1% of patients presented with STS of TB, including low fever, fatigue, emaciation, and night sweats. High fever may also occur during the acute phase of TB. Typical STS of TB can contribute to the diagnosis of STB; however, 67.9% of our patients lacked such symptoms.

STB is prone to cause neurological injury and the rate of disability is high. The incidence of neurological impairment in patients with STB reportedly varies from 23% to 76% \[[@B14]\]. In this study, 49.9% patients had neurologic impairment, 1.5% of them having ASIA Grade A and 2.8% Grade B, which represent severe neurologic damage. Patients with STB and neurologic impairment often need surgical treatment to create space to enable nerve recovery. Impaired neural function can recover to different degrees after surgery; however, recovery in patients with severe neurologic impairment is characteristically poor.

STB often involves two vertebrae because the segmental arteries bifurcate to supply two adjacent vertebrae. Spread of MTB beneath the anterior or posterior longitudinal ligaments can also result in involvement of multiple contiguous vertebrae. In this study, 67.9% of patients had two involved adjacent vertebrae, which comprised one motion segment. The most frequently involved vertebrae were lumbar, followed by thoracic. This localization may be related to the anatomical factors of high level of mobility and load forces in the lumbar region and the long segments in the thoracic region. The incidence was only 0.8% in sacrococcygeal vertebrae, likely because of its short segments, low mobility, and low load forces. Abscess formation around a vertebral lesion, which is not uncommon and prone to extreme enlargement, is another characteristic feature of STB. In this study, 65.5% of patients had abscesses. The 34.5% without abscesses may be more difficult to diagnose. Differential diagnoses include other diseases that cause bone destruction, such as spinal tumors.

Anti-TB drug treatment is the gold standard for the treatment of STB, whereas surgical treatment plays an important role as adjuvant therapy. The aim of surgery is to completely remove a lesion, achieve spinal decompression, reconstruct spinal stability, and restore a normal spinal sequence \[[@B15]\]. In this study, 72.6% of inpatients underwent surgery and their cure rate was as high as 88.2%. The relapse rate was 3.5% (49 patients). Reasons for recurrence may include erratic anti-TB drug treatment, malnutrition, comorbidities, and inadequate rest. The patients with relapses were all cured by revision surgery, including debridement, drainage, and focal catheter infusion with anti-TB drugs.

Five percent of patients with PTB reportedly have accompanying STB \[[@B16], [@B17]\]. Approximately 33%--50% of patients with STB have an associated primary lung focus or report a history of PTB \[[@B18]\]. In our study, 26.6% of patients with STB had accompanying PTB. We found that concomitant STB and PTB had the following characteristics. This combination was more common in male patients and was associated with abscesses, STS, neurological injury, and non-operative treatment. The influence of smoking, drinking and other lifestyle factors \[[@B19]\] may account for the predominance of PTB in men. Given that the STS of fever and night sweats are commonly present in patients with PTB, it is unsurprising that they are also common in patients with STB and PTB. The probability of abscess and neurological injury may be related to the extent of lesion; the specific reasons need further study. Patients with STB complicated by active PTB are prone to undergo conservative treatment. Surgery may cause spread of MTB.

The prevalence of TB was three to six times higher in patients with diabetes than in those without diabetes; additionally, the incidence of TB was three times higher in patients with poorly controlled diabetes than in those with ideally controlled diabetes \[[@B20]\]. Active TB, being an infection, can aggravate diabetes and may even induce acute ketoacidosis. Patients with diabetes and TB usually have the characteristics of long course, severe illness, rapid progression, and slow rehabilitation, which make treatment difficult \[[@B21], [@B22]\]. Moreover, patients with diabetes and STB have impaired anti-infection and tissue repair ability. Internal fixation and implants \[[@B23]\] are often needed for STB surgery. Active infection often exacerbates the patient\'s condition and affects the prognosis, sometimes leading to failure of surgery \[[@B24]\]. In our study, 63 patients (4.6%) had accompanying diabetes. We found that patients with STB and diabetes had the following characteristics. They were more commonly aged over 45 years and were prone to have STS and undergo non-surgical treatment. In addition, their prognosis was relatively poor. If surgery is needed in these patients, attention should be paid to the following: infection, wound healing \[[@B25]\], osteoporosis \[[@B26]\], stability of internal fixation \[[@B27]\] and vascular lesions \[[@B28]\].

The following limitations of this study are worth noting. First, the number of patients was relatively small and they were all inpatients. Because data on them is inadequate and difficult to obtain, outpatients were not included in this study; this may have resulted in a bias in outcomes, such as the higher rate of surgery and no HIV/AIDS case. Second, results of tests for drug resistance were unavailable.

5. Conclusions {#sec5}
==============

STB remains a severe problem endangering the public health and cannot be ignored. Most patients ignore its symptoms and therefore receive untimely treatment. Thus, surveillance for and treatment of STB should be strengthened in south-central China. In addition to the existing database for PTB, a database of patients with STB should be set up throughout China.
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###### 

Demographics and epidemiology of inpatients with STB.

  Year       Gender   Age (yeas)   Residence   Occupation   Total                                                   
  ---------- -------- ------------ ----------- ------------ ------- ------ ------ ------ ------ ------ ----- ------ ------
  2007       70       46           7           53           42      14     84     32     59     24     10    23     116
  2008       82       56           11          58           41      28     96     42     67     30     12    29     138
  2009       65       58           15          52           33      23     91     32     65     22     16    20     123
  2010       86       60           10          66           38      32     122    24     75     24     14    33     146
  2011       75       56           6           61           33      31     101    30     71     21     9     30     131
  2012       91       60           10          71           31      39     115    36     69     30     13    39     151
  2013       79       69           13          59           43      33     99     49     65     28     14    41     148
  2014       75       46           6           42           47      26     76     45     56     21     7     47     121
  2015       101      69           11          63           46      50     122    48     79     27     17    47     170
  2016       81       53           11          36           49      38     97     37     53     32     16    33     134
                                                                                                                    
  Total      805      573          100         561          403     314    1003   375    659    259    128   332    1378
  Rate (%)   58.4     41.6         7.3         40.7         29.2    22.8   72.8   27.2   47.8   18.8   9.3   24.1    
  *χ*2       4.583    46.592       20.252      30.756                                                               
  P          0.869    0.011        0.016                    0.281                                                   

###### 

Clinical presentation of inpatients with STB.

  Year       Back pain   Radiating pain   Systemic toxicity symptoms   Neurological injury                                          
  ---------- ----------- ---------------- ---------------------------- --------------------- ------ ------ ----- ----- ----- ------ ------
  2007       108         8                55                           61                    38     78     2     3     6     50     55
  2008       127         11               60                           78                    47     91     1     2     10    58     67
  2009       109         14               49                           74                    39     84     2     2     14    40     65
  2010       134         12               51                           95                    44     102    1     3     13    64     65
  2011       118         13               49                           82                    47     84     3     2     13    50     63
  2012       142         9                52                           99                    66     85     4     5     12    52     78
  2013       139         9                59                           89                    37     111    2     6     8     61     71
  2014       116         5                56                           65                    29     92     1     3     11    33     73
  2015       154         16               56                           114                   52     118    2     6     9     52     101
  2016       128         6                65                           69                    44     90     3     6     15    57     53
                                                                                                                                    
  Total      1275        103              552                          826                   443    935    21    38    111   517    691
  Rate (%)   92.5        7.5              40.1                         59.9                  32.1   67.9   1.5   2.8   8.1   37.5   50.1
  *χ*2       9.607       16.782           18.017                       26.902                                                       
  P          0.383       0.052            0.035                        0.081                                                        

###### 

Imaging findings of inpatients with STB.

  Year       Lesion sites   Involved number of vertebrae   Abscess                                                       
  ---------- -------------- ------------------------------ --------- ----- ------ ----- ----- ----- ------ ------ ------ ------
  2007       6              5                              53        7     39     6     0     10    81     25     75     41
  2008       8              8                              59        11    40     11    1     16    92     30     87     51
  2009       5              4                              49        16    39     9     1     12    86     25     80     43
  2010       11             3                              59        12    47     13    1     17    104    25     98     48
  2011       2              7                              52        12    47     9     2     6     85     40     89     42
  2012       8              1                              55        10    60     14    3     13    101    37     109    42
  2013       11             3                              49        9     68     8     0     14    97     37     90     58
  2014       12             2                              28        14    52     12    1     10    79     32     81     40
  2015       12             2                              53        10    80     11    2     15    124    31     112    58
  2016       13             6                              35        8     55     17    0     10    86     38     82     52
                                                                                                                         
  Total      88             41                             492       109   527    110   11    123   935    320    903    475
  Rate (%)   6.4            3.0                            35.7      7.9   38.2   8.0   0.8   8.9   67.9   23.2   65.5   34.5
  *χ*2       81.027         17.655                         6.582                                                         
  P          0.01           0.479                          0.681                                                         

C: Cervical; CT: Cervicothoracic; T: Thoracic; TL: Thoracolumbar; L: Lumbar; LS: Lumbosacral; S: Sacrococcygeal.

###### 

Correlation analysis between STB and PTB.

  Variate                      Type   Without PTB   With PTB   Total   *χ*2   P               
  ---------------------------- ------ ------------- ---------- ------- ------ ------ -------- -------
  Gender                       Male   573           56.6       232     63.4   805    5.068    0.024
  Female                       439    43.4          134        36.6    573                    
  Abscess                      Yes    644           63.6       259     70.8   903    6.047    0.014
  No                           368    36.4          107        29.2    475                    
  Surgery                      Yes    776           76.7       224     61.2   1000   32.347   0.000
  No                           236    23.3          142        38.8    378                    
  Systemic toxicity symptoms   Yes    305           30.1       138     37.7   443    7.055    0.008
  No                           707    69.9          228        62.3    935                    
  Neurological injury          Yes    480           47.4       207     56.6   687    8.955    0.003
  No                           532    52.6          159        43.4    691                    
  Prognosis                    Cure   891           88.0       319     87.2   1214   0.490    0.484
  Others                       121    12.0          47         12.8    163                    

###### 

Correlation analysis between STB and diabetes.

  Variate                      Type   Without diabetes   With diabetes   Total   *χ*2   P               
  ---------------------------- ------ ------------------ --------------- ------- ------ ------ -------- -------
  Age (yeas)                   \>45   662                50.3            55      87.3   717    32.904   0.000
  ≦45                          653    49.7               8               12.7    661                    
  Systemic toxicity symptoms   Yes    415                31.6            28      44.4   443    4.576    0.032
  No                           900    68.4               35              55.6    935                    
  Surgery                      Yes    966                73.4            34      54.0   1000   11.474   0.001
  No                           349    26.6               29              46.0    378                    
  Prognosis                    Cure   1167               88.7            48      76.2   1215   9.086    0.003
  Others                       148    11.3               15              23.8    163                    

###### 

Comparison of 10 years\' data.

  --------------------------------------------------------------------------------------------------------
  Variate                        Type            Group A   Group B   Total   *χ*2   P              
  ------------------------------ --------------- --------- --------- ------- ------ ------ ------- -------
  Gender                         Male            378       57.8      427     59     805    0.197   0.657

  Female                         276             42.2      297       41      573                   

  Age (yeas)                     ≦60             526       80.4      538     74.3   1064   7.312   0.007

  \>60                           128             19.6      186       25.7    314                   

  Residence                      Rural           494       75.5      509     70.3   1003   4.747   0.029

  Urban                          160             24.5      215       29.7    375                   

  Occupation                     Medical staff   6         0.9       16      2.2    22     4.154   0.046

  Others                         648             99.1      708       97.8    1356                  

  Back pain                      Yes             596       91.1      679     93.8   1275   3.497   0.061

  No                             58              8.9       45        6.2     103                   

  Radicular pain                 Yes             264       40.4      288     39.6   552    0.049   0.825

  No                             390             59.6      436       60.4    826                   

  Systemic toxicity symptoms     Yes             215       32.9      228     31.5   443    0.301   0.583

  No                             439             67.1      496       68.5    935                   

  Abscess                        Yes             429       65.6      474     65.5   903    0.002   0.964

  No                             225             34.4      250       34.5    475                   

  Neurological injury            Yes             339       51.8      348     48.1   687    1.952   0.162

  No                             315             48.2      376       51.9    691                   

  Involved number of vertebrae   \<3             509       77.8      549     75.9   1058   0.771   0.380

  ≧3                             145             22.2      175       24.1    320                   

  Surgery                        Yes             488       68.5      512     70.7   1000   2.625   0.105

  No                             166             31.5      212       29.3    378                   

  PTB                            Yes             176       26.9      190     26.2   366    0.079   0.779

  No                             478             73.1      534       73.8    1012                  

  Diabetes                       Yes             23        3.5       40      5.5    63     3.176   0.075

  No                             631             96.5      684       94.5    1315                  

  Prognosis\                     Cure            567       86.7      648     89.5   1215   2.593   0.107

  Others                         87              13.3      76        11.9    163                   
  --------------------------------------------------------------------------------------------------------

[^1]: Academic Editor: Frederick D. Quinn
